Turning the Tide: South Korea’s Breakthrough in Cancer Treatment

In a landmark finding, South Korean researchers have discovered how to reprogram cancer cells into normal tissue without chemotherapy or radiation. The new technique, applied to colorectal cancer, could transform cancer therapy by shifting from devastation to rejuvenation.

How the Breakthrough Works

Researchers at the Korea Advanced Institute of Science and Technology (KAIST) used a computer model called BENEIN to map gene relationships between cancer cells

The top three genes that play the most critical regulatory roles—MYB, HDAC2, and FOXA2—are determined in this research to specify a cell's malignancy or non-malignancy

By turning off these genes, researchers managed to inhibit cancer cell growth and induce normal-like behavior

Lab and Animal Test Results

The method was also tested on human colorectal cancer cells, which revealed a dramatic loss of tumor growth

When treated cells were implanted in mice, the developed tumors were less malignant and smaller compared to untreated controls

Gene expression confirmed that reprogrammed cells exhibited features of normal intestine tissue, suppressing cancer-related pathways

Future Outlook and Challenges

Scientists believe that the process can be adapted for other cancers, an alternative option less invasive than current treatments

Long-term stability of reprogrammed cells remains a challenge, additional studies required

If clinically established, this approach could revolutionize cancer treatment from destruction to reprogramming with fewer side effects

Sources: MSN, Business Today, Moneycontrol, OncoDaily.